Purpura: Causes, Types, Warning Signs, Diagnosis, and Treatment

Purpura is a non-blanching hemorrhage into the skin or mucous membranes, measuring more than 2 millimeters. Unlike inflammatory rashes, these lesions do not fade with pressure, as they represent not temporary vasodilation but rather the leakage of blood into the tissue. Manuals and dermatological reference books emphasize that purpura can be flat or palpable, and essentially reflects one of two major mechanisms: impaired hemostasis or inflammatory damage to the vascular wall. [1]

It's important to distinguish purpura from petechiae and ecchymoses. Petechiae are smaller than 2 millimeters, purpura is larger, and large areas of subcutaneous hemorrhage are usually called ecchymoses, or bruises. This is not just a formal classification: the size and texture of the lesions help the physician determine whether a platelet disorder, coagulopathy, vasculitis, or a severe infectious process is involved. [2]

It is especially important to distinguish between non-palpable and palpable purpura. Non-palpable purpura is more often associated with thrombocytopenia, coagulation disorders, increased vascular fragility, and hemorrhages without significant vascular inflammation. Palpable purpura is considered a classic sign of leukocytoclastic vasculitis and other forms of cutaneous small vessel vasculitis. [3]

Purpura can be relatively harmless or extremely dangerous. Sometimes it occurs after drug-induced thrombocytopenia, mechanical stress, or local vascular injury. In other cases, it is the first noticeable sign of thrombotic thrombocytopenic purpura, meningococcal infection, immunoglobulin A vasculitis, blood diseases, or purpura fulminans.[4]

That's why the word "purpura" in medicine should never be reassuring on its own, nor should it be frightening on its own. It's a description of an external phenomenon, not a ready-made diagnosis. The doctor's primary goal is to understand why blood has leaked into the skin, whether there is a systemic disease, and whether urgent care is required. [5]

Sign	Petechiae	Purpura	Ecchymosis
Size	Up to 2 millimeters	More than 2 millimeters	Large area of hemorrhage
Disappears when pressed	No	No	No
Relief	Usually flat	May be flat or palpable	Usually flat
The most typical mechanism	Pinpoint capillary hemorrhage	Hemorrhage or vascular inflammation	More extensive subcutaneous hemorrhage
Important clinical clue	Often seen in platelet disorders	The palpable form suggests vasculitis.	Often with trauma or coagulopathy

The source of the table is based on a dermatological description of the elements and a review of non-blanching hemorrhages.[6]

Why does purpura occur?

There are a few primary pathophysiological mechanisms. These include a decrease in platelet count, impaired platelet function, deficiency or consumption of coagulation factors, and damage to the vascular wall. Sometimes, increased pressure in small vessels or a combination of several mechanisms is added, for example, in sepsis or thrombotic microangiopathy. [7]

If purpura is non-palpable, the physician first considers thrombocytopenia or another hemostatic disorder. With a decreased platelet count, petechiae, mucosal bleeding, nosebleeds, bleeding gums, and a tendency to bruise are also typical. A review of platelet disorders emphasizes that mucocutaneous bleeding is the key clinical clue in this group. [8]

If the purpura is palpable, meaning the lesions are slightly raised and denser than the surrounding skin, this significantly increases the likelihood of cutaneous vasculitis. The Merck Manual lists palpable purpura as a characteristic feature of leukocytoclastic vasculitis. This pattern may be limited to the skin, or it may be part of a systemic process related to infection, medications, autoimmune disease, or malignancy. [9]

In children, one of the most well-known causes of palpable purpura is immunoglobulin A vasculitis, formerly known as Henoch-Schonlein purpura. It is the most common systemic vasculitis of childhood, typically presenting with palpable purpura, joint pain, abdominal syndrome, and possible renal involvement. A current review estimates the annual incidence in children to be approximately 3-27 cases per 100,000.[10]

A particularly dangerous variant is purpura fulminans. This is a rapidly progressing hemorrhagic and thrombotic skin disorder associated with microvascular thrombosis, disseminated intravascular coagulation, and often sepsis. A StatPearls review called it a true dermatologic emergency because it rapidly leads to skin necrosis, shock, and multiple organ failure. [11]

Mechanism	Typical reasons	Which purpura is more common?
Decreased platelet count	Immune thrombocytopenia, leukemia, sepsis, drug-induced thrombocytopenia	Non-palpable
Platelet dysfunction	Drugs, hereditary thrombocytopathy, von Willebrand disease	Non-palpable
Coagulation disorder	Disseminated intravascular coagulation, liver disease, factor deficiencies	Usually non-palpable
Inflammation of the vascular wall	Cutaneous vasculitis, immunoglobulin A vasculitis, drug-induced vasculitis	Palpable
Microvascular thrombosis	Thrombotic thrombocytopenic purpura, purpura fulminans	May progress rapidly with necrosis
Mechanical vascular injury	Pressure, trauma, vascular fragility	Most often limited and non-palpable

The source of the table is based on reviews of nonblanching eruptions, platelet disorders, and cutaneous vasculitis.[12]

How the appearance of purpura helps us understand the cause

The appearance of purpura provides the physician with a wealth of information even before testing. Flat, non-palpable purpura often indicates a problem with platelets, coagulation, or vascular fragility. Palpable purpura, on the other hand, is much more strongly associated with vascular inflammation and therefore suggests vasculitis. [13]

Location is also important. Palpable purpura on the shins and buttocks is particularly typical of cutaneous small-vessel vasculitis and immunoglobulin A vasculitis. In an updated review of immunoglobulin A vasculitis, the classic tetrad includes palpable purpura, arthralgia or arthritis, gastrointestinal manifestations, and glomerulonephritis. [14]

If the lesions rapidly darken, merge, become painful, form blisters, areas of ischemia, or necrosis, this is a very alarming sign. This course can occur with purpura fulminans, severe disseminated intravascular coagulation, sepsis, and some vasculitides. In these cases, the purpura ceases to be simply a "skin hemorrhage" and becomes an external manifestation of a microvascular catastrophe. [15]

Purpura associated with fever and rapidly deteriorating symptoms requires a separate assessment for bacterial infection, particularly meningococcal infection. NICE states that the presence of purpura in children is a highly specific and moderately sensitive sign of meningococcal disease, while petechiae alone without purpura are less specific. A spreading rash and lesions involving the trunk and lower extremities are particularly concerning. [16]

The appearance of the rash should be assessed along with other symptoms. Purpura plus joint and abdominal manifestations suggest immunoglobulin A vasculitis. Purpura plus mucous bleeding suggests a platelet disorder. Purpura plus fever, hypotension, and altered consciousness suggest sepsis and purpura fulminans. Purpura plus neurological and renal signs suggest thrombotic thrombocytopenic purpura. [17]

External sign	The most likely direction of diagnosis
Flat non-blanching purpura	Thrombocytopenia, coagulopathy, vascular fragility
Palpable purpura on the shins	Cutaneous small vessel vasculitis
Purpura on the buttocks and legs of a child with abdominal pain	Immunoglobulin A vasculitis
Rapid darkening, necrosis, fusion of elements	Purpura fulminans, severe coagulopathy
Purpura with fever and poor general condition	Sepsis, meningococcal infection
Purpura with mucous bleeding	Platelet disorder

The source of the table is based on dermatology and hematology guidelines and reviews on vasculitis.[18]

When purpura requires urgent help

Not all purpura is an emergency, but there are situations where delay is dangerous. The most important combination is purpura with fever, worsening general condition, drowsiness, severe pain, hypotension, difficulty breathing, or altered consciousness. In this context, the rash may be a manifestation of meningococcal disease, sepsis, or purpura fulminans. [19]

NICE emphasizes that a non-blanching rash, including purpuric rash, is a significant red flag for bacterial meningitis and meningococcal infection in children, adolescents, and adults. Additional warning signs include cold extremities, delayed capillary refill, tachypnea, tachycardia, decreased consciousness, and signs of shock. Even if the initial lesions are few, a rapidly spreading rash is particularly dangerous. [20]

Thrombotic thrombocytopenic purpura is another condition where delay is unacceptable. The Merck Manual and StatPearls describe it as an acute fulminant thrombotic microangiopathy with thrombocytopenia, microangiopathic hemolytic anemia, and possible brain and kidney damage. If suspected, a person should not be kept in the outpatient setting without urgent hematological care. [21]

A separate emergency is purpura fulminans. It progresses rapidly, accompanied by cutaneous necrosis, disseminated intravascular coagulation, and circulatory collapse. A StatPearls review emphasizes that patients are often severely ill, with fever, bleeding from multiple sites, and hypotension. [22]

In children and adolescents, purpura following bloody diarrhea, purpura with severe abdominal pain, oliguria, edema, vomiting, or seizures require particular concern. Hemolytic uremic syndrome and severe forms of immunoglobulin-A vasculitis with renal involvement must be quickly excluded. In pregnant women, purpura requires rapid exclusion of thrombocytopenia of pregnancy, preeclampsia, and hemolysis syndrome, elevated liver enzymes, and thrombocytopenia. [23]

Situation	Why urgent help is needed
Purpura plus fever	Sepsis and meningococcal infection are possible
Purpura plus a drop in blood pressure or cold extremities	Shock is possible
Rapidly progressive necrotizing purpura	Suspected purpura fulminans
Purpura plus neurological symptoms	Thrombotic thrombocytopenic purpura and meningitis must be excluded.
Purpura plus oliguria or blood in the urine	Renal involvement is possible
Purpura in a pregnant woman with headache or abdominal pain	Severe obstetric pathology must be excluded.

The source of the table is based on NICE, StatPearls and Merck Manual.[24]

How is the diagnosis made: what does the doctor evaluate first?

Diagnosis of purpura always begins with a medical history and physical examination. Important factors to consider include the time of onset of the rash, its rate of spread, the presence of fever, mucosal bleeding, joint pain, abdominal syndrome, infections in recent weeks, new medications, pregnancy, and a family history of bleeding. A 2024 review for primary care emphasizes that a detailed medical history and photographs of the rash can be significantly helpful in identifying the cause of bleeding and purpura. [25]

During the examination, the physician assesses whether the lesions are pale, whether they are palpable, their location, bruising, bleeding gums, nosebleeds, hepatosplenomegaly, lymph nodes, edema, and signs of systemic disease. This helps quickly differentiate between cutaneous vasculitis, platelet problems, coagulopathy, and severe infection. Palpable purpura is particularly suggestive of vasculitis and often requires a skin biopsy. [26]

Basic laboratory testing typically includes a complete blood count (CBC) with platelets, a peripheral blood smear, prothrombin time (PT), activated partial thromboplastin time (APT), and liver and kidney function tests. If a systemic disease is suspected, inflammatory markers, urinalysis, infection testing, and immunological testing are added. This approach is recommended in both primary care and hematology practices. [27]

If cutaneous vasculitis is suspected, diagnosis often involves a skin biopsy. The Merck Manual explicitly states that the diagnosis of cutaneous vasculitis requires a biopsy, especially if it is necessary to differentiate a limited cutaneous process from systemic vasculitis or a drug reaction. A biopsy is most informative on a freshly prepared active ingredient. [28]

If thrombotic thrombocytopenic purpura is suspected, signs of microangiopathic hemolysis, decreased platelet count, and ADAMTS13 enzyme activity are crucial. However, treatment is not initiated after weeks of waiting for results, but rather when the clinical probability is high. Therefore, diagnosis and treatment are conducted in parallel. [29]

Diagnostic step	What is it for?
Detailed anamnesis	Helps link purpura to infection, medication, vasculitis, pregnancy, or heredity
Examination of the skin and mucous membranes	Shows the type of bleeding and the severity of the condition
Complete blood count and platelets	Reveals thrombocytopenia, anemia, leukocytosis
Peripheral blood smear	Looks for schistocytes, blasts, and other key changes
Coagulogram	Helps differentiate coagulopathy from platelet causes
Skin biopsy	Needed if vasculitis is suspected
Urinalysis and biochemistry	Allows identification of renal and systemic involvement

The source of the table is based on a review of the Primary Evaluation of Bleeding Disorders, the Merck Manual, and platelet disorders guidelines.[30]

How is purpura treated?

Purpura is not treated as a separate disease. The underlying condition is treated. Therefore, topical treatments and "rash ointments" do not resolve the problem in most cases. In some cases, observation is sufficient, while in others, corticosteroids, plasma exchange, antibiotics, intensive care, or urgent hematological intervention are required. [31]

If immune thrombocytopenia is the cause, treatment depends on age, platelet count, and severity of bleeding. The American Society of Hematology guidelines recommend observation in adults with mild cutaneous manifestations and platelet counts of 30 × 10⁹ per liter or higher, and a short course of corticosteroids in those with more severe thrombocytopenia. For protracted thrombocytopenia in adults, thrombopoietin receptor agonists, rituximab, or fostamatinib are more commonly discussed after corticosteroids in modern algorithms. [32]

In children with immune thrombocytopenia and only cutaneous manifestations, a watchful waiting approach is often possible. This is important because the disease often resolves spontaneously in children. However, if there is mucosal bleeding, significant daily restrictions, or more severe clinical symptoms, corticosteroids or intravenous immunoglobulin are considered. [33]

If purpura is caused by cutaneous vasculitis, treatment depends on the severity and systemic nature of the condition. With limited cutaneous purpura, eliminating the trigger, especially if it's a drug or infection, is sometimes sufficient, along with rest, leg elevation, and symptomatic therapy. With more severe cases, corticosteroids and other immunosuppressive agents may be used, but the choice depends on whether internal organs are affected. [34]

In many children with immunoglobulin A vasculitis, treatment is primarily supportive, as the disease is often self-limiting. However, in cases of severe abdominal pain, significant skin symptoms, renal involvement, or the more severe adult variant, glucocorticoids and sometimes other immunosuppressive approaches are used. An updated review from 2024 emphasizes that the course of the disease in adults is often more severe than in children, particularly in cases of nephritis. [35]

Thrombotic thrombocytopenic purpura requires immediate plasma exchange and corticosteroids, and in modern practice is often supplemented with rituximab and caplacizumab. This is one condition where delayed therapy significantly worsens the prognosis. Therefore, in cases of high clinical suspicion, treatment is initiated before final laboratory confirmation. [36]

Purpura fulminans is treated in an intensive care setting. The mainstays of treatment are sepsis treatment, antibiotic therapy as indicated, hemodynamic support, correction of coagulopathy, and sometimes anticoagulation and protein C replacement or fresh frozen plasma in the appropriate clinical context. DermNet and StatPearls emphasize that this is a multi-step therapy requiring the participation of infectious disease specialists, hematologists, intensive care specialists, and surgeons. [37]

Cause of purpura	Basic treatment approach
Mechanical or limited benign	Monitoring and eliminating the provoking factor
Immune thrombocytopenia in adults	Observation or corticosteroids, then targeted therapy as indicated
Immune thrombocytopenia in a child	Frequently monitor, in case of bleeding immunoglobulin or corticosteroids
Cutaneous vasculitis without systemic involvement	Elimination of the cause, symptomatic therapy, sometimes corticosteroids
Immunoglobulin A vasculitis	Supportive therapy, in severe cases glucocorticoids and other treatments for organ damage
Thrombotic thrombocytopenic purpura	Urgent plasma exchange, corticosteroids, modern hematological regimens
Purpura fulminans	Intensive care, treatment of sepsis and coagulopathy

The source of the table is based on ASH, Merck Manual, DermNet and current reviews on vasculitis.[38]

What is the prognosis and can purpura be prevented?

The prognosis for purpura is highly variable. If it is a mild cutaneous form without systemic involvement or a transient episode with a reversible trigger, the outcome is usually good. However, if purpura is a manifestation of sepsis, thrombotic microangiopathy, or severe vasculitis with renal involvement, the prognosis is determined not by the condition of the skin, but by the degree of systemic involvement. [39]

In children, immunoglobulin A vasculitis often has a benign outcome. A recent review indicates that the prognosis for children is generally good, while adults are less frequently affected but more severely, and renal damage in them more often leads to permanent sequelae. This is one example of how the same purpura has different long-term consequences in different age groups. [40]

In adults, immune thrombocytopenia often becomes chronic, although severe bleeding does not occur in all cases. In children, immune thrombocytopenia often develops acutely and often resolves spontaneously. Therefore, the same appearance of purpura in a child and an adult may indicate different monitoring strategies and long-term prognoses. [41]

There is no specific prevention for "purpura in general" because it is a symptom, not a single disease. Prevention involves prompt treatment of infections, judicious medication use, management of chronic diseases, minimizing skin trauma, vaccinations as indicated, and early treatment for a non-blanching rash accompanied by fever or bleeding. [42]

The rule of thumb is simple: rare, limited purpura without deterioration in health isn't always dangerous, but purpura as a new symptom always deserves careful attention. It's much safer to get a blood test promptly and rule out a dangerous cause than to try to reassure yourself based solely on the appearance of the lesions. [43]

Clinical situation	Estimated forecast
Mild localized purpura without systemic symptoms	Often favorable
Immune thrombocytopenia in a child	Often self-limiting course
Immune thrombocytopenia in adults	Often chronic course
Immunoglobulin A vasculitis in a child	Usually good with kidney control
Immunoglobulin A vasculitis in adults	More cautious due to the risk of nephritis
Thrombotic thrombocytopenic purpura and purpura fulminans	Serious, highly dependent on the urgency of treatment

The source of the table is based on contemporary reviews of immune thrombocytopenia, immunoglobulin A vasculitis, and purpura fulminans.[44]

FAQ

Are purpura and an allergic rash the same thing?
No. Purpura doesn't fade when pressed because it's a hemorrhage into the skin. An allergic inflammatory rash is more likely to fade and is usually caused by a different mechanism. [45]

Does palpable purpura always indicate vasculitis?
This is often the opinion of clinicians, as palpable purpura is considered a classic sign of leukocytoclastic vasculitis. However, a definitive diagnosis requires clinical evaluation and often a skin biopsy. [46]

Is it possible to tell at home whether purpura is dangerous or not?
Definitely not. But high fever, weakness, rapid spread, dark necrotic lesions, mucous bleeding, oliguria, neurological symptoms, and pregnancy make the situation more worrisome and require urgent evaluation. [47]

Is purpura always associated with low platelets?
No. It can occur with normal platelet counts if the cause is vasculitis, platelet dysfunction, coagulopathy, or microvascular thrombosis. [48]

Should I treat purpura with ointments?
Usually not. Topical treatments rarely affect the underlying mechanism of purpura. The key is to understand the cause and treat the underlying condition. [49]

Which purpura is considered the most dangerous?
From a clinical perspective, purpura fulminans, purpura associated with sepsis, and purpura associated with thrombotic thrombocytopenic purpura are particularly dangerous because they can all progress rapidly and be life-threatening. [50]

Key points from experts

Expert	Regalia	Practical thesis
James N. George	MD, Professor, Hematologist, University of Oklahoma; long-time researcher of platelet disorders and thrombotic microangiopathies [51]	In purpura, it is particularly important to distinguish relatively stable thrombocytopenia from thrombotic microangiopathy, because apparently similar hemorrhages may require very different urgency of treatment. [52]
Donald M. Arnold	MD, MS, Professor of Medicine, Co-Director of the Centre for Transfusion Research, McMaster University [53]	In patients with purpura due to immune thrombocytopenia, not only the platelet count is important, but also the type of bleeding, age, concomitant diseases, and the real probability of severe bleeding. [54]
Peter A. Merkel	MD, MPH, Professor of Medicine and Epidemiology, Chief of Rheumatology at the University of Pennsylvania, Internationally Recognized Expert on Vasculitis [55]	Palpable purpura is a clinical clue to vascular inflammation and should not be assessed solely as a skin problem without trying to understand whether the process is limited to the skin or whether internal organs are already involved.[56]